HEADER SIGNALING PROTEIN 28-NOV-17 6F3I TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,S.L.DEGORCE,G.R.ROBB,A.D.FERGUSON REVDAT 1 23-MAY-18 6F3I 0 JRNL AUTH S.L.DEGORCE,R.ANJUM,K.S.DILLMAN,L.DREW,S.D.GROOMBRIDGE, JRNL AUTH 2 C.T.HALSALL,E.M.LENZ,N.A.LINDSAY,M.F.MAYO,J.H.PINK,G.R.ROBB, JRNL AUTH 3 J.S.SCOTT,S.STOKES,Y.XUE JRNL TITL OPTIMIZATION OF PERMEABILITY IN A SERIES OF PYRROLOTRIAZINE JRNL TITL 2 INHIBITORS OF IRAK4. JRNL REF BIOORG. MED. CHEM. V. 26 913 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29398441 JRNL DOI 10.1016/J.BMC.2018.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 PACIOREK REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 37321 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1841 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2864 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2265 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2731 REMARK 3 BIN R VALUE (WORKING SET) : 0.2254 REMARK 3 BIN FREE R VALUE : 0.2474 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.64 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4300 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 81.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.22450 REMARK 3 B22 (A**2) : -8.19550 REMARK 3 B33 (A**2) : 6.97100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.369 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.240 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.198 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.242 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.200 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4439 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5983 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1601 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 127 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 614 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4439 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 570 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5176 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.47 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.52 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -16.2537 -29.4081 -16.9204 REMARK 3 T TENSOR REMARK 3 T11: 0.3303 T22: -0.1304 REMARK 3 T33: -0.3790 T12: 0.4246 REMARK 3 T13: 0.0401 T23: 0.0077 REMARK 3 L TENSOR REMARK 3 L11: 3.1397 L22: 1.6300 REMARK 3 L33: 4.1936 L12: -0.7708 REMARK 3 L13: -1.8795 L23: 0.6139 REMARK 3 S TENSOR REMARK 3 S11: -0.4111 S12: -0.2214 S13: -0.2901 REMARK 3 S21: 0.0453 S22: 0.1965 S23: -0.1402 REMARK 3 S31: 1.1881 S32: 0.7857 S33: 0.2147 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -55.6386 -25.1263 -15.1872 REMARK 3 T TENSOR REMARK 3 T11: 0.2580 T22: -0.0915 REMARK 3 T33: -0.4057 T12: -0.2203 REMARK 3 T13: -0.0255 T23: -0.0207 REMARK 3 L TENSOR REMARK 3 L11: 2.2580 L22: 1.9009 REMARK 3 L33: 4.8738 L12: -0.9381 REMARK 3 L13: -1.1865 L23: 0.5621 REMARK 3 S TENSOR REMARK 3 S11: 0.2049 S12: 0.4062 S13: -0.0483 REMARK 3 S21: -0.0977 S22: -0.1821 S23: 0.1704 REMARK 3 S31: 0.6241 S32: -0.8515 S33: -0.0228 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6F3I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007707. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37360 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 67.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.50800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.5, 0.02% REMARK 280 OCTYLGLUCOSIDE, 10% GLYCEROL, 0.3 M NACL, 1 MM TCEP, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.48500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.94200 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.48500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.94200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.48500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.94200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.48500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.94200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 139 REMARK 465 HIS A 140 REMARK 465 HIS A 141 REMARK 465 HIS A 142 REMARK 465 HIS A 143 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 HIS A 146 REMARK 465 GLU A 147 REMARK 465 ASN A 148 REMARK 465 LEU A 149 REMARK 465 TYR A 150 REMARK 465 PHE A 151 REMARK 465 GLN A 152 REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ARG A 164 REMARK 465 PRO A 184 REMARK 465 ILE A 185 REMARK 465 SER A 186 REMARK 465 VAL A 187 REMARK 465 GLY A 188 REMARK 465 GLY A 195 REMARK 465 GLY A 196 REMARK 465 PHE A 197 REMARK 465 GLY A 198 REMARK 465 ASN A 206 REMARK 465 ASN A 207 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 SER A 253 REMARK 465 ASP A 254 REMARK 465 GLY A 255 REMARK 465 ASP A 256 REMARK 465 ASP A 257 REMARK 465 LEU A 258 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 MET B 139 REMARK 465 HIS B 140 REMARK 465 HIS B 141 REMARK 465 HIS B 142 REMARK 465 HIS B 143 REMARK 465 HIS B 144 REMARK 465 HIS B 145 REMARK 465 HIS B 146 REMARK 465 GLU B 147 REMARK 465 ASN B 148 REMARK 465 LEU B 149 REMARK 465 TYR B 150 REMARK 465 PHE B 151 REMARK 465 GLN B 152 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 310 -5.11 77.44 REMARK 500 ASP A 311 45.95 -143.92 REMARK 500 ASP A 329 89.16 60.09 REMARK 500 HIS A 390 49.20 -97.11 REMARK 500 ASP B 181 102.01 -51.67 REMARK 500 ASN B 207 -3.73 69.94 REMARK 500 GLU B 224 -51.31 -144.09 REMARK 500 ARG B 310 -4.42 77.00 REMARK 500 ASP B 311 45.20 -144.13 REMARK 500 ASP B 329 84.47 62.74 REMARK 500 HIS B 390 49.10 -96.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CKN A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CKN B 502 DBREF 6F3I A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 6F3I B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 SEQADV 6F3I MET A 139 UNP Q9NWZ3 INITIATING METHIONINE SEQADV 6F3I HIS A 140 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 141 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 142 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 143 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 144 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 145 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS A 146 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLU A 147 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I ASN A 148 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I LEU A 149 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I TYR A 150 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I PHE A 151 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLN A 152 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I MET B 139 UNP Q9NWZ3 INITIATING METHIONINE SEQADV 6F3I HIS B 140 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 141 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 142 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 143 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 144 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 145 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I HIS B 146 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLU B 147 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I ASN B 148 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I LEU B 149 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I TYR B 150 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I PHE B 151 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLN B 152 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6F3I GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 322 MET HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 322 GLN GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG SEQRES 3 A 322 PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR SEQRES 4 A 322 ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN SEQRES 5 A 322 LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY SEQRES 6 A 322 TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA SEQRES 7 A 322 ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN SEQRES 8 A 322 PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS SEQRES 9 A 322 GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY SEQRES 10 A 322 ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SEQRES 11 A 322 SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO SEQRES 12 A 322 PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY SEQRES 13 A 322 ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS SEQRES 14 A 322 ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP SEQRES 15 A 322 GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA SEQRES 16 A 322 ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP SEQRES 17 A 322 ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA SEQRES 18 A 322 LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER SEQRES 19 A 322 PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO SEQRES 20 A 322 ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP SEQRES 21 A 322 ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU SEQRES 22 A 322 ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SEQRES 23 A 322 SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU SEQRES 24 A 322 HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL SEQRES 25 A 322 GLN GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 322 MET HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 B 322 GLN GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG SEQRES 3 B 322 PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR SEQRES 4 B 322 ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN SEQRES 5 B 322 LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY SEQRES 6 B 322 TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA SEQRES 7 B 322 ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN SEQRES 8 B 322 PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS SEQRES 9 B 322 GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY SEQRES 10 B 322 ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SEQRES 11 B 322 SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO SEQRES 12 B 322 PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY SEQRES 13 B 322 ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS SEQRES 14 B 322 ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP SEQRES 15 B 322 GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA SEQRES 16 B 322 ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP SEQRES 17 B 322 ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA SEQRES 18 B 322 LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER SEQRES 19 B 322 PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO SEQRES 20 B 322 ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP SEQRES 21 B 322 ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU SEQRES 22 B 322 ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SEQRES 23 B 322 SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU SEQRES 24 B 322 HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL SEQRES 25 B 322 GLN GLN LEU LEU GLN GLU MET THR ALA SER MODRES 6F3I TPO A 345 THR MODIFIED RESIDUE MODRES 6F3I SEP A 346 SER MODIFIED RESIDUE MODRES 6F3I TPO B 345 THR MODIFIED RESIDUE MODRES 6F3I SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET CKN A 501 31 HET SO4 B 501 5 HET CKN B 502 31 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM CKN (3~{R})-3-[4-[[4-(4-ETHANOYLPIPERAZIN-1-YL) HETNAM 2 CKN CYCLOHEXYL]AMINO]PYRROLO[2,1-F][1,2,4]TRIAZIN-5- HETNAM 3 CKN YL]BUTANAMIDE HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 CKN 2(C22 H33 N7 O2) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *111(H2 O) HELIX 1 AA1 SER A 169 ASN A 175 1 7 HELIX 2 AA2 LYS A 227 CYS A 240 1 14 HELIX 3 AA3 SER A 269 SER A 275 1 7 HELIX 4 AA4 CYS A 276 THR A 280 5 5 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 LYS A 313 ALA A 315 5 3 HELIX 7 AA7 THR A 351 MET A 355 5 5 HELIX 8 AA8 ALA A 356 ARG A 361 1 6 HELIX 9 AA9 THR A 365 GLY A 383 1 19 HELIX 10 AB1 LEU A 395 LEU A 397 5 3 HELIX 11 AB2 ASP A 398 ASP A 405 1 8 HELIX 12 AB3 ASP A 422 LEU A 437 1 16 HELIX 13 AB4 LYS A 440 ARG A 444 5 5 HELIX 14 AB5 ASP A 446 THR A 458 1 13 HELIX 15 AB6 SER B 169 THR B 177 1 9 HELIX 16 AB7 PRO B 184 GLY B 188 5 5 HELIX 17 AB8 GLU B 224 CYS B 240 1 17 HELIX 18 AB9 SER B 269 SER B 275 1 7 HELIX 19 AC1 CYS B 276 THR B 280 5 5 HELIX 20 AC2 SER B 284 ASN B 305 1 22 HELIX 21 AC3 LYS B 313 ALA B 315 5 3 HELIX 22 AC4 THR B 351 MET B 355 5 5 HELIX 23 AC5 ALA B 356 GLY B 362 1 7 HELIX 24 AC6 THR B 365 GLY B 383 1 19 HELIX 25 AC7 LEU B 395 LEU B 397 5 3 HELIX 26 AC8 ASP B 398 ASP B 405 1 8 HELIX 27 AC9 ASP B 422 LEU B 437 1 16 HELIX 28 AD1 LYS B 440 ARG B 444 5 5 HELIX 29 AD2 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 PHE A 251 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 LEU A 260 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 VAL A 210 LYS A 213 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 200 TYR A 201 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 193 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 5 LYS B 191 GLU B 194 0 SHEET 2 AA3 5 VAL B 199 VAL B 205 -1 O VAL B 200 N MET B 192 SHEET 3 AA3 5 THR B 208 LYS B 214 -1 O THR B 208 N VAL B 205 SHEET 4 AA3 5 CYS B 259 VAL B 263 -1 O LEU B 260 N LYS B 213 SHEET 5 AA3 5 LEU B 248 SER B 252 -1 N SER B 252 O CYS B 259 SHEET 1 AA4 2 HIS B 307 ILE B 308 0 SHEET 2 AA4 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA5 2 ILE B 317 LEU B 319 0 SHEET 2 AA5 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.35 LINK C SEP B 346 N ARG B 347 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 0.10 CISPEP 2 GLU B 392 PRO B 393 0 -0.76 SITE 1 AC1 13 MET A 192 ALA A 211 TYR A 262 VAL A 263 SITE 2 AC1 13 MET A 265 ASP A 272 LEU A 277 ALA A 315 SITE 3 AC1 13 ASN A 316 LEU A 318 SER A 328 ASP A 329 SITE 4 AC1 13 HOH A 617 SITE 1 AC2 3 ASP A 422 SER A 423 ASN B 207 SITE 1 AC3 14 MET B 192 GLU B 194 GLY B 195 ALA B 211 SITE 2 AC3 14 TYR B 262 VAL B 263 MET B 265 ASP B 272 SITE 3 AC3 14 LEU B 277 ALA B 315 ASN B 316 LEU B 318 SITE 4 AC3 14 SER B 328 HOH B 624 CRYST1 86.516 108.970 141.884 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011559 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009177 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007048 0.00000